Frontiers in Medicine (Mar 2024)

Case report: A novel PTCH1 frameshift mutation leading to nevoid basal cell carcinoma syndrome

  • Xiaoqing Lang,
  • Ting Wang,
  • Shuping Guo,
  • Yao Dang,
  • Yingjie Zhang,
  • Hongye Liu,
  • Hongxia He,
  • Li Li,
  • Huajie Yuan,
  • Ting He,
  • Qiong Wang,
  • Shiyu Qin,
  • Runping Cheng,
  • Xingquan Yan,
  • Hongzhou Cui

DOI
https://doi.org/10.3389/fmed.2024.1327505
Journal volume & issue
Vol. 11

Abstract

Read online

A patient presenting with several basal cell carcinomas, pigmented nevi, and developmental defects was diagnosed with nevoid basal cell carcinoma syndrome. Gene panel sequencing and Sanger sequencing were used to identify a novel heterozygous frameshift mutation, c.1312dupA:p.Ser438Lysfs, in exon 9 of PTCH1. I-Tasser and PyMol analyses indicated that the mutated protein patched homolog 1 (PTCH1) lacked 12 transmembrane domains and the intracellular and extracellular rings of ECD2 compared with the wild-type protein, resulting in a remarkably different structure from that of the wild-type protein. This case extends our knowledge of the mutation spectrum of NBCCS.

Keywords